Company overview
Basic information
Company name
DNA Namai, MB
Company code
305739005
Registered address
Vilnius, Dilgynės g. 11A, LT-11307
Registration date
2021-04-20
Company age: 5 y. 6 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Architectural activities
Ownership form
Private without foreign capital
MB DNA Namai
Company code: 305739005
Address: Vilnius, Dilgynės g. 11A, LT-11307
Description
This description was generated by artificial intelligence.
DNA Namai, MB (company code 305739005) is an operational private small partnership registered on 20 April 2021. It is classified as a micro company in the national private non-financial companies sector and is privately owned, with more than 50% of the authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is described as CEO only. The company is based in Vilnius, at Dilgynes g. 11A, LT-11307, Vilniaus m. sav., Vilniaus apskr. Its main activity is EVRK N.71.11.00, Architectural activities.
Financially, the company has shown growth over the latest three financial years. Revenue increased from €29.2K in 2023 to €30.9K in 2024 and reached €44.8K in 2025, which represents 44.8% year-on-year growth in the latest year and 53.6% growth over two years. Net profit rose from €14.3K in 2023 to €7.8K in 2024 and €12.6K in 2025, while the profit margin improved to 28.1% in 2025 from 25.3% in 2024. At the end of 2025, equity stood at €32.4K, liabilities at €6.6K, and total assets at €39.1K. The company’s equity ratio was 83.0%, with debt to equity at 0.20 and asset turnover at 1.15x.
Financially, the company has shown growth over the latest three financial years. Revenue increased from €29.2K in 2023 to €30.9K in 2024 and reached €44.8K in 2025, which represents 44.8% year-on-year growth in the latest year and 53.6% growth over two years. Net profit rose from €14.3K in 2023 to €7.8K in 2024 and €12.6K in 2025, while the profit margin improved to 28.1% in 2025 from 25.3% in 2024. At the end of 2025, equity stood at €32.4K, liabilities at €6.6K, and total assets at €39.1K. The company’s equity ratio was 83.0%, with debt to equity at 0.20 and asset turnover at 1.15x.
Download a detailed company report
Make confident decisions with all the information about DNA Namai, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.